AI uncovers Eli Lilly's rheumatoid arthritis drug Olumiant as potential...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Mar 8, 2021 at 10:52 AM.

  1. #1 cafead, Mar 8, 2021 at 10:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via Could janus kinase (JAK) inhibitors like Eli Lilly’s rheumatoid arthritis drug Olumiant be repurposed to treat Alzheimer’s disease? Researchers at Harvard University and Massachusetts General Hospital have set out to find the answer to that question with a new clinical trial that was born from artificial intelligence.

    article source
     
    Quote

Reply to Thread